missing translation for 'onlineSavingsMsg'
Learn More

Invitrogen™ CNTO 607 Biosimilar Recombinant Monoclonal Antibody
GREENER_CHOICE

Recombinant Monoclonal Antibody

£397.00 - £1002.00

Specifications

Antigen CNTO 607 Biosimilar
Concentration 1 mg/mL
Content And Storage -20°C, Avoid Freeze/Thaw Cycles
Applications ELISA, Flow Cytometry, Functional Assay, Surface Plasmon Resonance
Classification Recombinant Monoclonal
View More Specs

Products 2
Product Code Brand Quantity Price Quantity & Availability  
Product Code Brand Quantity Price Quantity & Availability  
30283578
GREENER_CHOICE
View Documents
Invitrogen™
MA559169
100 μg
£397.00
100µg
View alternative products
Save Up to 
»
Please to purchase this item. Need a web account? Register with us today!
30284193
View Documents
Invitrogen™
MA559170
1 mg
£1002.00
1mg
View alternative products
Save Up to 
»
Please to purchase this item. Need a web account? Register with us today!
Description

Description

For reconstitution, add sterile, distilled water to achieve a final antibody concentration of 1 mg/mL. Gently shake to solubilize the protein completely. Do not vortex. Reconstituted products should be stored at -80 °. This antibody can also be cross referenced by the term CNTO 607.

IL13 (Interleukin-13) is a gene located on chromosome 5q31, encoding the IL-13 cytokine, which plays a pivotal role in the immune system, particularly in the regulation of inflammatory and immune responses. IL-13 is predominantly secreted by Th2 cells and is involved in the pathogenesis of allergic reactions and chronic inflammatory conditions such as asthma and ulcerative colitis. This cytokine exerts its effects by binding to the IL-13 receptor complex, which includes IL-13R aplha 1 and IL-4R alpha. Upon binding, IL-13 activates several signaling pathways, including the JAK-STAT pathway, leading to the transcription of genes involved in the immune response. IL-13 is also implicated in tissue remodeling and fibrosis due to its ability to stimulate fibroblast proliferation and collagen production. Dysregulation of IL-13 expression or signaling is associated with various diseases, making it a target for therapeutic intervention, particularly in allergic and autoimmune conditions.
Specifications

Specifications

CNTO 607 Biosimilar
-20°C, Avoid Freeze/Thaw Cycles
Recombinant Monoclonal
Lyophilized
IgG1
Human
Primary
Protein A
1 mg/mL
ELISA, Flow Cytometry, Functional Assay, Surface Plasmon Resonance
Unconjugated
Human
RUO
25mM histidine with 8% sucrose, 0.01% Tween 80 and no preservative; pH 6.2
Antibody
Videos
SDS
Documents

Documents

Product Certifications
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.